8-[8-[3-[3-tert-butyl-1-(4-methylphenyl)pyrazol-5-yl]-2-oxopropyl]quinolin-5-yl]oxy-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;8-[8-[3-[2-fluoro-5-(trifluoromethyl)phenyl]-2-oxopropyl]quinolin-5-yl]oxy-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one
C61H50F4N10O6 — CID 159375127
Data last refreshed: (MolForge compound catalog, from PubChem)
About 8-[8-[3-[3-tert-butyl-1-(4-methylphenyl)pyrazol-5-yl]-2-oxopropyl]quinolin-5-yl]oxy-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;8-[8-[3-[2-fluoro-5-(trifluoromethyl)phenyl]-2-oxopropyl]quinolin-5-yl]oxy-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one
8-[8-[3-[3-tert-butyl-1-(4-methylphenyl)pyrazol-5-yl]-2-oxopropyl]quinolin-5-yl]oxy-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;8-[8-[3-[2-fluoro-5-(trifluoromethyl)phenyl]-2-oxopropyl]quinolin-5-yl]oxy-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one (PubChem CID 159375127) has the molecular formula C61H50F4N10O6 and a molecular weight of 1095.13 g/mol. Its IUPAC name is 8-[8-[3-[3-tert-butyl-1-(4-methylphenyl)pyrazol-5-yl]-2-oxopropyl]quinolin-5-yl]oxy-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;8-[8-[3-[2-fluoro-5-(trifluoromethyl)phenyl]-2-oxopropyl]quinolin-5-yl]oxy-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one.
Molecular Properties
| Compound Name | 8-[8-[3-[3-tert-butyl-1-(4-methylphenyl)pyrazol-5-yl]-2-oxopropyl]quinolin-5-yl]oxy-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;8-[8-[3-[2-fluoro-5-(trifluoromethyl)phenyl]-2-oxopropyl]quinolin-5-yl]oxy-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one |
|---|---|
| PubChem CID | 159375127 |
| Molecular Formula | C61H50F4N10O6 |
| Molecular Weight | 1095.13 g/mol |
| Exact Mass | 1094.39 |
| IUPAC Name | 8-[8-[3-[3-tert-butyl-1-(4-methylphenyl)pyrazol-5-yl]-2-oxopropyl]quinolin-5-yl]oxy-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one;8-[8-[3-[2-fluoro-5-(trifluoromethyl)phenyl]-2-oxopropyl]quinolin-5-yl]oxy-2-methyl-4H-pyrido[2,3-b]pyrazin-3-one |
| SMILES | Cc1ccc(-n2nc(C(C)(C)C)cc2CC(=O)Cc2ccc(Oc3ccnc4[nH]c(=O)c(C)nc34)c3cccnc23)cc1.Cc1nc2c(Oc3ccc(CC(=O)Cc4cc(C(F)(F)F)ccc4F)c4ncccc34)ccnc2[nH]c1=O |
| InChI | InChI=1S/C34H32N6O3.C27H18F4N4O3/c1-20-8-11-23(12-9-20)40-24(19-29(39-40)34(3,4)5)18-25(41)17-22-10-13-27(26-7-6-15-35-30(22)26)43-28-14-16-36-32-31(28)37-21(2)33(42)38-32;1-14-26(37)35-25-24(34-14)22(8-10-33-25)38-21-7-4-15(23-19(21)3-2-9-32-23)12-18(36)13-16-11-17(27(29,30)31)5-6-20(16)28/h6-16,19H,17-18H2,1-5H3,(H,36,38,42);2-11H,12-13H2,1H3,(H,33,35,37) |
| InChIKey | LKFGUDILDAMIDY-UHFFFAOYSA-N |
| XLogP | 11.59 |
| TPSA | 213.48 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 81 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1095.13 |
| LogP ≤ 5 | 11.59 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 14 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159375127 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.